Sampre Nutritions Limited, a flagship of the **Gurbani Group**, is a premier Indian confectionery manufacturer with over **40 years** of operational expertise. The company has evolved from a manual production house into a technology-driven B2B partner for global FMCG giants. Specializing in sugar-boiled candies, toffees, and nutraceuticals, Sampre is currently undergoing a strategic transformation characterized by aggressive international expansion, a shift toward "affordable luxury," and a comprehensive restructuring of its capital base. --- ### **Strategic B2B Partnerships & Manufacturing Ecosystem** Sampre operates primarily as a high-compliance manufacturing partner for multinational corporations (MNCs) and domestic leaders. Its revenue model is anchored by processing charges and long-term strategic alliances. * **Blue-Chip Client Portfolio:** The company maintains long-standing associations (some exceeding **30 years**) with industry leaders including **Mondelez International**, **Nestle**, **ITC**, **Dabur India**, **Himalaya Wellness**, **Cipla**, and **Procter & Gamble** (for whom it manufactures Vicks Cough Drops for the Japanese market). * **New High-Value Contracts:** * **Reliance Consumer Products Limited (RCPL):** A 3-year agreement (Oct 2025) projected to generate **₹12–15 crores** annually. * **Tolaram Wellness Ltd:** A 3-year contract (Aug 2025) expected to yield **₹10 crores** annually. * **PRAN Beverages (India) Pvt Ltd:** A July 2024 agreement for **200 Tons per month**, valued at **₹25–30 crores** annually. * **Rama Exports:** An August 2025 agreement projected at **₹15 crores** over the contract term. * **Operational Infrastructure:** The company operates three specialized units in Telangana: * **Unit 1 (Owned):** Medchal, Telangana (Registered Office & Works). * **Unit 2 (Leased):** Medchal, Malkajgiri, Telangana. * **Unit 3 (Operational):** Jeedimetla, Hyderabad. --- ### **Product Innovation: From Confectionery to Nutraceuticals** The company is pivoting its portfolio to align with global health trends and the "accessible luxury" segment, leveraging data-led flavor innovation and collaborations with global flavor houses. * **Health & Wellness:** Development of **sugar-free**, **high-protein**, and **fortified vitaminized candies** designed for preventative health. * **Artisanal & Premium:** Positioning handcrafted treats and personalized gifting solutions for the rising middle-class disposable income. * **Social Impact:** An MoU with the **African Peace and Security Union** to manufacture fortified candies for women and children in nutritional-challenge zones. * **Sustainability:** Commitment to **ethical sourcing** of Cocoa, Sugar, and Palm Oil, alongside the adoption of **recyclable and biodegradable packaging**. --- ### **Global Expansion & International Footprint** Sampre is aggressively scaling its presence beyond India, targeting high-growth emerging markets through dedicated international subsidiaries. * **International Entities:** **Sampre Nutritions FZCO** (Dubai, UAE) and **Sampre Nutritions Holding Limited** (England, UK). * **Egypt Industrial Hub:** In **February 2026**, the company signed a Land Purchase and Allocation Agreement with **Orascom Industrial Parks** to establish manufacturing operations in Egypt. * **African Market Entry:** Identification of **Liberia (Monrovia)** as a key growth region for fortified confectionery products. * **Compliance:** Holds **HACCP**, **Halal**, and **FSSC 22000 Version VI** certifications, ensuring seamless entry into regulated global markets. --- ### **Financial Performance & Capital Restructuring** The company has recently undertaken significant corporate actions to deleverage its balance sheet and fund its expansionary phase. **Standalone Financial Summary:** | Metric | FY 2024-25 | FY 2023-24 | FY 2022-23 | | :--- | :--- | :--- | :--- | | **Total Income** | **₹25.12 Crore** | **₹25.15 Crore** | **₹37.11 Crore** | | **Profit / (Loss) After Tax** | **₹(7.31) Crore** | **₹30.95 Lakhs** | **₹34.70 Lakhs** | | **Debt-Equity Ratio** | **0.18x** | **0.78x** | **1.96x** | | **Current Ratio** | **1.16x** | **1.29x** | **1.08x** | **Key Corporate Actions (2024-2025):** * **FCCB Issuance & Conversion:** Approved **USD 40 Million** in Foreign Currency Convertible Bonds. Significant portions have already been converted into equity (e.g., **13 bonds** converted into **7.62 million shares** in Dec 2025). * **Deleveraging:** Converted an unsecured promoter loan of **₹7.44 Crore** into **1.77 million equity shares** at **₹42/share** to reduce interest liability. * **Stock Split & Bonus:** Sub-divided shares from **FV ₹10 to FV ₹5** and issued a **1:1 bonus** in late 2025. * **Capital Increase:** Authorized capital increased from **₹35 Crores to ₹100 Crores** in September 2025. --- ### **Operational Agility & Efficiency Models** To combat rising costs and improve margins, Sampre has overhauled its internal processes and cost structures. * **Organizational Flattening:** Reduced management layers from **9 to 4** to accelerate decision-making. * **Digital Migration:** Transitioned from SAP to a **Tally-based MIS** to reduce order processing time. * **Variable Cost Structure:** Shifted after-sales and labor-intensive functions to a **Distributor Partnership Model**, converting fixed costs into variable expenses. * **Logistics:** Utilizing quick commerce channels, which saw impulse item deliveries rise over **150% YoY**. --- ### **Risk Profile & Mitigation Strategies** Despite growth initiatives, the company faces several critical headwinds that investors must monitor. * **Going Concern & Profitability:** Auditors issued an **Emphasis of Matter** regarding the **₹7.31 Crore** net loss in FY25, raising doubts about operational viability. Management is countering this through new high-margin contracts and deleveraging. * **Statutory & Regulatory Compliance:** The company has faced delays in depositing **GST, PF, and Income Tax** dues. It also received a modified opinion for failing to submit the **Structured Digital Database (SDD)** certificate under SEBI Insider Trading regulations. * **Commodity Volatility:** Cocoa prices surged past **USD 12,000/MT** in 2025; sugar availability remains subject to Indian export controls. * **Macro-Economic Pressures:** New **U.S. tariffs of up to 50%** on Indian exports and rising logistics costs pose threats to export margins. * **Liquidity:** **Debtor Days** increased to **128.5 days** in FY25, indicating a need for more stringent receivables management.